The staining results showed that the expression levels of CD31 were increased in the FBXO22-overexpressing tumor group (Fig. 6E), while its expression in the shFBXO22 tumor group was decreased compared with that in the shNC tumor group (Fig. 6F). Here, PECAM1 is linked to neoplasm.